4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-23-021751
Chief Executive Officer bought 15,021 shares at an average $0.54 ($8,061)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2023-06-15 | Purchase | +21 | $0.50 | $11 | 57,521 | D |
| Huntsman Ronald Kirk Chief Executive Officer | 2023-06-16 | Purchase | +10,000 | $0.54 | $5,400 | 67,521 | D |
| Huntsman Ronald Kirk Chief Executive Officer | 2023-06-16 | Purchase | +5,000 | $0.53 | $2,650 | 72,521 | D |
| Open-market purchases · 15,021 sh · avg $0.54 · $8,061 | |||||||
Loading xslF345X04/ownership.xml…